Three Monthly Injections Versus One Initial Injection of Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: 12-Month Results of a Prospective Randomized Study

INTRODUCTION: To compare three monthly injections versus one initial injection of intravitreal ranibizumab (IVR) followed by pro re nata (PRN) dosing to treat macular edema secondary to branch retinal vein occlusion (BRVO). METHODS: Seventy-four patients were randomized (1:1) to the 3 + PRN or 1 + P...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Wenyi, Guo, Jingli, Xu, Gezhi, Liu, Wei, Chang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587151/
https://www.ncbi.nlm.nih.gov/pubmed/36223056
http://dx.doi.org/10.1007/s40123-022-00588-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587151/
https://www.ncbi.nlm.nih.gov/pubmed/36223056
http://dx.doi.org/10.1007/s40123-022-00588-7

Ejemplares similares